The new urine drug tests and cutoffs offered under EDI’s DrugCheck brand bring the total number of tests available for export to 39. The new test strips will be of particular interest to international customers where several of the focus drugs have become much more prevalent in recent years. In addition to previously available tests, DrugCheck onsite cups and dip tests can now screen for clonazepam, EDDP, fentanyl, GHB, methadone (200 ng/mL), tramadol, and 16 different synthetic marijuana/cannabis (K2) compounds.
DrugCheck urine cups and dip tests are FDA 510(k) cleared for 17 drugs of abuse. The additional 22 drugs and cutoffs included in the expanded catalog of custom drug tests and cutoffs are available for export or forensic use only.
Visitors to the 2013 AACC Clinical Lab Expo can find Express Diagnostics Int’l at booth 1835/1837.
About Express Diagnostics Int’l, Inc.
Express Diagnostics Int’l manufactures and distributes DrugCheck® on-site urine and saliva screening devices for the detection of drugs of abuse, as well as a growing catalog of health screening devices. With accuracy comparable to laboratory testing, Express Diagnostics onsite devices provide a variety of industries fast, cost-effective alternatives to higher-priced lab services. Learn more at drugcheck.com.
Copyright©2012 Vocus, Inc.
All rights reserved